Regional forearm blood flow and net metabolite flux during baseline and isoprenaline infusion in lean and obese subjects
. | Lean . | . | Obese . | . | ||
---|---|---|---|---|---|---|
. | Baseline . | ISO . | Baseline . | ISO . | ||
n | 13 | 10 | 10 | 7 | ||
FBF (ml · 100 ml−1 tissue · min−1) | 2.9 ± 0.2 | 4.6 ± 0.4* | 2.5 ± 0.3 | 3.5 ± 0.3* | ||
Forearm net flux (nmol · 100 ml−1 tissue · min−1) | ||||||
TAG | 17 ± 5 | 24 ± 19† | −2 ± 9† | 46 ± 31† | ||
FFA | 6 ± 59† | −53 ± 143† | 156 ± 42 | 230 ± 88 | ||
Glycerol | −21 ± 11† | −39 ± 33† | 11 ± 5†‡ | 6 ± 21† | ||
Glucose | 142 ± 51 | 213 ± 117† | 226 ± 81 | 289 ± 223† | ||
Lactate | −90 ± 27 | −171 ± 73 | 8 ± 45 | −327 ± 78 |
. | Lean . | . | Obese . | . | ||
---|---|---|---|---|---|---|
. | Baseline . | ISO . | Baseline . | ISO . | ||
n | 13 | 10 | 10 | 7 | ||
FBF (ml · 100 ml−1 tissue · min−1) | 2.9 ± 0.2 | 4.6 ± 0.4* | 2.5 ± 0.3 | 3.5 ± 0.3* | ||
Forearm net flux (nmol · 100 ml−1 tissue · min−1) | ||||||
TAG | 17 ± 5 | 24 ± 19† | −2 ± 9† | 46 ± 31† | ||
FFA | 6 ± 59† | −53 ± 143† | 156 ± 42 | 230 ± 88 | ||
Glycerol | −21 ± 11† | −39 ± 33† | 11 ± 5†‡ | 6 ± 21† | ||
Glucose | 142 ± 51 | 213 ± 117† | 226 ± 81 | 289 ± 223† | ||
Lactate | −90 ± 27 | −171 ± 73 | 8 ± 45 | −327 ± 78 |
Data are means ± SE. Positive flux = net uptake; negative flux = net release.
P < 0.05 ISO vs. baseline.
Exchange not different from zero.
P < 0.05 obese vs. lean.